Kozlovsky V.I., Simanovich A.V.
Adherence to therapy in patients with the second degree arterial hypertension. Literature review and the authors’ data
Abstract.
The review of literature presents current data on the issue of adherence to antihypertensive therapy in different countries. Identifying factors associated with adherence will allow to justify the execution of a number of measures to improve the effectiveness of hypertensive patients treatment. To assess the level of adherence to treatment in patients with II degree hypertension in Belarus and to identify factors associated with it was the aim of this study. The study included 182 patients, whose mean age made up 55,8±6,8 years. An individual profile was filled in for each patient, where the prescribed treatment and regularity of medication were indicated. The evaluation of adherence to therapy was carried out by Morisky-Green test, evaluation of the health level – by means of visual analogue scale. SF-36 questionnaire was used to assess the quality of life, the level of reactive and personal anxiety was assessed by Spielberg-Hanin self-appraisal method.
The causes of poor adherence to antihypertensive treatment were revealed: male gender, disease duration less than 5 years, smoking, high indices of life quality by SF-36 questionnaire, the level of health on visual analogue scale over 60, high and medium level of reactive and personal anxiety, treatment with one antihypertensive medicine, side effects of medicines, lack of blood pressure and antihypertensive medication self-monitoring by keeping a diary, lack of outpatient observation for hypertension. Patients who had had stroke and/or myocardial infarction were determined to have greater adherence to therapy.
Increase of adherence to treatment in patients with II degree hypertension can be achieved by means of keeping a diary to control arterial blood pressure and antihypertensive medication.
Key words: arterial hypertension, adherence to therapy.
References
1. Benetos A , Zureik M, Morcet J, Thomas F, Bean K, Safar M, Ducimetière P, Guize L. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a heart cardiovascular mortality in men. J Am Coll Cardiol. 2000 Mar;35(3):673-80.
2. Shal'nova SA, Deev AD, Oganov RG. Faktory, vliiaiushchie na smertnost' ot serdechno-sosudistykh zabolevanii v rossiiskoi populiatsii [Factors influencing mortality from cardiovascular diseases in the Russian population]. Kardiovaskuliarnaia terapiia i profilaktika. 2005;4(1):4-9.
3. Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? J Cardiovasc Pharmacol. 2000;35(3):23-6.
4. Konradi AO, Polunicheva EV. Nedostatochnaia priverzhennost' k lecheniiu arterial'noi gipertenzii: prichiny i puti korrektsii [Lack of adherence to the treatment of hypertension: causes and correction]. Arterial'naia gipertenziia. 2004;10(3):137-43.
5. Oshchepkova EV, Isaeva LG. Nizkaia priverzhennost' bol'nykh arterial'noi gipertoniei k lecheniiu: podkhody k ee uluchsheniiu [Low adherence of hypertensive patients to treatment: approaches to improve it]. Atmosfera. Kardiologiia: zhurnal dlia praktikuiushchikh vrachei. 2003;(3):33-6.
6. Bourgault C, Rainville B, Suissa S. Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension. Arch Intern Med. 2001 Aug;161(15):1873-9.
7. Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S, Baio G, Capone A, Sturani A. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002 Aug;24(8):1347-57
8. Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens. 2004 Oct;22(10):1849-55.
9. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006 Jul;333(7557):15.
10. Khokhlov AL, Lisenkova LA, Rakov AA. Analiz faktorov, opredeliaiushchikh priverzhennost' k antigipertenzivnoi terapii [Analyzing the determinants of adherence to antihypertensive therapy]. Kachestvennaia klinicheskaia praktika. 2003;(4):59-66.
11. Neutel JM, Smith DH. Improving patient compliance: a major goal in the management of hypertension. J Clin Hypertens (Greenwich). 2003 Mar-Apr;5(2):127-32.
12. Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010 May;48(5):418-25.
13. Jokisalo E, Enlund H, Halonen P, Takala J, Kumpusalo E. Factors related to poor control of blood pressure with antihypertensive drug therapy. Blood Press. 2003;12(1):49-55.
14. Veronesi M, Cicero Arrigo FG, Prandin MG, Dormi A, Cosentino E, Strocchi E, Borghi C. A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vasc Health Risk Manag. 2007 Dec; 3(6): 999-1005.
15. Aranda P, Ruilope LM, Calvo C, Luque M, Coca A, Gil de Miguel A. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. Am J Hypertens. 2004 Feb;17(2):139-45.
16. Petrov VI, Reshet'ko OV, Lutsevich KA, Frolov MYu. Klinicheskaia farmakologiia: tendentsiia global'nogo razvitiia i vybor rossiiskoi modeli [Clinical pharmacology: the trend of global development and the choice of the Russian model]. Klinicheskaia farmakologiia i terapiia. 2011;20(5):25-31.
17. Schoberberger R, Janda M, Pescosta W, Sonneck G. The Compliance Praxis Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medication. J Hum Hypertens. 2002 Nov;16(11):779-87.
18. Konradi AO, Soboleva AV, Maksimova TA, Polunicheva EV, Brodskaia IS, Shliakhto EV. Obuchenie bol'nykh gipertonicheskoi bolezn'iu - bessmyslennaia trata vremeni ili real'nyi instrument v povyshenii kachestva kontrolia zabolevaniia? [Training of patients by an idiopathic hypertensia - a senseless waste of time or the real tool in improvement of quality of control of a disease?]. Arterial'naia gipertenziia. 2002;8(6):217-20.
19. Serov VA, Gorbunov VI. Vliianie sotsial'no-ekonomicheskikh faktorov na priverzhennost' k lecheniiu bol'nykh gipertonicheskoi bolezn'iu [Influence of socio-economic factors on commitment to treatment of patients by an idiopathic hypertensia]. Klinicheskaia meditsina. 2007;85(3):65-8.
20. Ragot S, Sosner P, Bouche G, Guillemain J, Herpin D. Appraisal of the knowledge of hypertensive patient and assessment of the role of the pharmacists in the management of hypertension: results of a regional survey. J Hum Hypertens. 2005 Jul;19(7):577-84.
21. Sarradon-Eck A, Egrot M, Blanc M-A, Faure M. Anthropological Approach to Adherence Factors for Antihypertensive Drugs. Healthc Policy. 2010 May;5(4):157-175.
22. Krzesinski JM, Krzesinski F. M. Importance of a bad adherence to the antihypertensive treatment in the hypertensive population. How to improve it? Rev Med Liege. 2010 May-Jun;65(5-6):278-84.
23. Oganov RG, red. Natsional'nye klinicheskie rekomendatsii [National clinical references]: sbornik. 3-e izd. Moscow, RF: Silitseia-Poligraf; 2010. 592 р.
24. Werlemann BC, Offers E, Kolloch R. Compliance problems in therapy resistant hypertension. Herz. 2004 May;29(3):271-5.
25. Chazov EI, Oganov RG, Pogosova GV, Deev AD, Shal'nova SA, Koltunov IE, Romasenko LV. Depressivnaia simptomatika ukhudshaet prognoz u bol'nykh arterial'noi gipertoniei i ishemicheskoi bolezn'iu serdtsa: pervye rezul'taty prospektivnogo etapa rossiiskogo mnogotsentrovogo issledovaniia KOORDINATA [The depressive symptomatology worsens the forecast at patients with an arterial hypertonia and coronary heart disease: first results of a prospektivny stage of the Russian multicenter research COORDINATE]. Kardiologiia. 2007;47(10):24-30.
26. Burnier M, Hess B, Greminger P, Waeber B. Determinants of persistence in hypertensive patients treated with Irbesartan: results of a postmarketing survey. BMC Cardiovasc Disords. 2005;(5):13.
27. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, Schwartz JS. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005 May;165(10):1147-52.
28. Alam MG, Barri YM. Systolic blood pressure is the main etiology for poorly controlled hypertension. Am J Hypertens. 2003 Feb;16(2):140-3.
29. Konradi AO. Znachenie priverzhennosti k terapii v lechenii kardiologicheskikh zabolevanii [Value of commitment to therapy in treatment of cardiologic diseases]. Spravochnik poliklinicheskogo vracha. 2007;(6):8-12.
30. Jadelson P, Vilas-Boas F, Chagas H, Andrade M. Epidemiological aspects of adherence to the treatment of hypertension. Arg Bras Cardiol. 2002;79(4):380-4.
31. Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. J Hypertens. 2000 Nov;18(11):1691-9.
32. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998 Jul-Aug;20(4):671-81.
33. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actualpractice data. CMAJ. 1999 Jan;160(1):41-6.
34. Morgan SG, Yan L. Persistence with hypertension treatment among community-dwelling BC seniors. Can J Clin Pharmacol. 2004;11(2):267-73.
35. Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De Ponti F, Montanaro N. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol. 2005 Sep;61(8):603-9.
36. Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australiawide experience, 2004-2006. Med J Aust. 2008 Feb;188(4):224-7.
37. Nedogoda SV, Marchenko IV, Chaliabi TA. Sravnitel'naia antigipertenzivnaia effektivnost' generikov angiotenzinprevrashchaiushchego fermenta enalaprila (reniteka, enapa, ednita, invorila, envansa i enama) i stoimost' lecheniia u bol'nykh gipertonicheskoi bolezn'iu [Comparative anti-hypertensive efficiency of generics of angiotenzinprevrashchayushchy enzyme of enalapril (reniteka, enapa, ednita, invorila, envansa and enama) and treatment cost at patients with an idiopathic hypertensia]. Arterial'naia gipertenziia. 2000;6(1):52-4.
38. Wannemacher AJ, Schepers GP, Townsend KA. Antihypertensive medication compliance in a Veterans Affairs Healthcare System. Ann Pharmacother. 2002 Jun;36(6):986-91.
39. Podzolkov VI. Novoe v diagnostike i lechenii arterial'noi gipertenzii: po materialam poslednikh rekomendatsii ESH/ESC [New in diagnostics and treatment of arterial hypertension: on materials of the last references of ESH/ESC]. Farmateka. 2007;(19):28-38.
40. Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res. 2011 Jan;34(1):87-90.
41. Diamantopoulos EJ, Andreadis EA, Vassilopoulos CV, Giannakopoulos NS, Papadopoulou P, Tsourous GI, Tsiftsis NH. Adherence to an intensive antihypertensive follow-up programme. J Hum Hypertens. 2003 Jun;17(6):437-9.
42. Mrochek AG, Nechesova TA, Korobko IYu, Liventseva MM, Pavlova OS, Pristrom AM. Diagnostika, lechenie i profilaktika arterial'noi gipertenzii: natsional'nye rekomendatsii [Diagnostics, treatment and prophylaxis of arterial hypertension: national references]. Minsk, RB: Professional'nye izdaniia; 2010. 52 р.
43. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of self-reported measure of medical adherence. Med Care. 1986 Jan;24(1):67-74.
44. Reips UD, Funke F. Interval level measurement with visual analogue scales in Internet-based research: VAS Generator. Behav Res Methods. 2008 Aug;40(3):699-704.
45. Mesnikova IL. Adaptirovannaia k usloviiam Respubliki Belarus' metodika otsenki kachestva zhizni bol'nykh i invalidov [Adapted for conditions of Republic of Belarus a technique of an assessment of quality of life of patients and disabled people]: metod. rekomendatsii. Minsk, RB: BGMU; 2005. 19 р.
